Literature DB >> 12468071

Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging.

Daisuke Takenaka1, Yoshiharu Ohno, Hiroto Hatabu, Chiho Ohbayashi, Masahiro Yoshimura, Yutaka Ohkita, Kazuro Sugimura.   

Abstract

OBJECTIVES: To differentiate between metastatic and non-metastatic lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo (SE) MR imaging. METHODS AND PATIENTS: One hundred and forty mediastinal lymph nodes were detected in 25 patients with non-small cell lung cancer who underwent respiratory-triggered STIR turbo SE imaging. Ratios of signal intensity of lymph nodes to 0.9% saline phantoms (lymph node-saline ratio) were compared by Student's t-test using the pathological diagnosis as the gold standard. The threshold value of the lymph node-saline ratio was determined for a positive test, and tested for its capability to provide a differential diagnosis.
RESULTS: One hundred and forty lymph nodes were diagnosed and classified into two groups: metastatic lymph node (n=21) and non-metastatic lymph node (n=119). The mean lymph node-saline ratio in the non-metastatic lymph node group (0.42+/-0.01; mean+/-standard error) was significantly lower than that of the metastatic lymph node group (0.77+/-0.02, P<0.0001). When 0.6 was adapted as the threshold for a positive test, sensitivity, specificity, and accuracy for differentiating metastatic lymph node from non-metastatic lymph node per lymph nodes were 100, 96, and 96%, and sensitivity, specificity, and accuracy for differentiating metastatic lymph node from non-metastatic lymph node per patients were 100, 75, and 88%, respectively.
CONCLUSIONS: Both metastatic and non-metastatic lymph nodes in patients with non-small cell lung cancer were well differentiated using respiratory-triggered STIR turbo SE imaging.

Entities:  

Mesh:

Year:  2002        PMID: 12468071     DOI: 10.1016/s0720-048x(02)00271-1

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Turbo short tau inversion recovery imaging for metastatic node screening in patients with head and neck cancer.

Authors:  Y Kawai; M Sumi; T Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

2.  A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer.

Authors:  Yoo Na Kim; Chin A Yi; Kyung Soo Lee; O Jung Kwon; Ho Yun Lee; Byung-Tae Kim; Joon Young Choi; Seon Woo Kim; Man Pyo Chung; Joungho Han; Tae Sung Kim; Myung Jin Chung; Young Mog Shim
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

Review 3.  Diagnostic imaging in the preoperative management of lung cancer.

Authors:  Kazuhiro Imai; Yoshihiro Minamiya; Hajime Saito; Satoru Motoyama; Yusuke Sato; Aki Ito; Kei Yoshino; Satoshi Kudo; Shinogu Takashima; Yasushi Kawaharada; Nobuyasu Kurihara; Kimito Orino; Jun-Ichi Ogawa
Journal:  Surg Today       Date:  2013-07-10       Impact factor: 2.549

Review 4.  Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

Authors:  Jessica C Sieren; Yoshiharu Ohno; Hisanobu Koyama; Kazuro Sugimura; Geoffrey McLennan
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

5.  Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer.

Authors:  Hajimu Gotoh; Naoki Kanomata; Masahiro Yoshimura; Yoshiharu Ohno; Takuya Moriya; Chiho Ohbayashi
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

Review 6.  Magnetic resonance imaging for N staging in non-small cell lung cancer: A systematic review and meta-analysis.

Authors:  Yuanyuan Zhang; Qin Qin; Baosheng Li; Juan Wang; Kun Zhang
Journal:  Thorac Cancer       Date:  2015-01-08       Impact factor: 3.500

7.  Apparent Diffusion Coefficient Measurement in Mediastinal Lymphadenopathies: Differentiation between Benign and Malignant Lesions.

Authors:  Fethi Emre Ustabasioglu; Cesur Samanci; Deniz Alis; Nilay Sengul Samanci; Osman Kula; Deniz Cebi Olgun
Journal:  J Clin Imaging Sci       Date:  2017-03-06

8.  SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.

Authors:  G Fernández-Pérez; R Sánchez-Escribano; A M García-Vicente; A Luna-Alcalá; J Ceballos-Viro; R C Delgado-Bolton; J C Vilanova-Busquets; P Sánchez-Rovira; M P Fierro-Alanis; R García-Figueiras; J E Alés-Martínez
Journal:  Clin Transl Oncol       Date:  2017-12-18       Impact factor: 3.405

Review 9.  State-of-the-art MR Imaging for Thoracic Diseases.

Authors:  Yumi Tanaka; Yoshiharu Ohno; Satomu Hanamatsu; Yuki Obama; Takahiro Ueda; Hirotaka Ikeda; Akiyoshi Iwase; Takashi Fukuba; Hidekazu Hattori; Kazuhiro Murayama; Takeshi Yoshikawa; Daisuke Takenaka; Hisanobu Koyama; Hiroshi Toyama
Journal:  Magn Reson Med Sci       Date:  2021-04-29       Impact factor: 2.760

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.